全文获取类型
收费全文 | 4644篇 |
免费 | 157篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 86篇 |
妇产科学 | 66篇 |
基础医学 | 590篇 |
口腔科学 | 61篇 |
临床医学 | 259篇 |
内科学 | 1200篇 |
皮肤病学 | 47篇 |
神经病学 | 349篇 |
特种医学 | 198篇 |
外科学 | 900篇 |
综合类 | 22篇 |
预防医学 | 86篇 |
眼科学 | 183篇 |
药学 | 235篇 |
中国医学 | 8篇 |
肿瘤学 | 524篇 |
出版年
2023年 | 19篇 |
2022年 | 44篇 |
2021年 | 96篇 |
2020年 | 48篇 |
2019年 | 65篇 |
2018年 | 78篇 |
2017年 | 61篇 |
2016年 | 99篇 |
2015年 | 101篇 |
2014年 | 137篇 |
2013年 | 177篇 |
2012年 | 294篇 |
2011年 | 309篇 |
2010年 | 141篇 |
2009年 | 135篇 |
2008年 | 265篇 |
2007年 | 310篇 |
2006年 | 269篇 |
2005年 | 299篇 |
2004年 | 307篇 |
2003年 | 291篇 |
2002年 | 297篇 |
2001年 | 63篇 |
2000年 | 53篇 |
1999年 | 77篇 |
1998年 | 60篇 |
1997年 | 67篇 |
1996年 | 56篇 |
1995年 | 57篇 |
1994年 | 57篇 |
1993年 | 60篇 |
1992年 | 44篇 |
1991年 | 45篇 |
1990年 | 29篇 |
1989年 | 29篇 |
1988年 | 23篇 |
1987年 | 15篇 |
1986年 | 22篇 |
1985年 | 18篇 |
1984年 | 16篇 |
1983年 | 25篇 |
1982年 | 18篇 |
1981年 | 19篇 |
1980年 | 16篇 |
1979年 | 10篇 |
1978年 | 15篇 |
1977年 | 9篇 |
1976年 | 11篇 |
1974年 | 14篇 |
1970年 | 9篇 |
排序方式: 共有4841条查询结果,搜索用时 15 毫秒
71.
Shiro Ono Kiyomi Yoshimoto Nobushiro Nishimura Ryo Yoneima Hiromasa Kawashima Tadanao Kobayashi Yoshiaki Tai Makiko Miyamoto Emiko Tsushima Noritaka Yada Kenji Nishio 《Internal medicine (Tokyo, Japan)》2021,60(8):1303
TAFRO syndrome is a systemic inflammatory, lymphoproliferative disorder, but the pathophysiology of the disease is unknown. It is typically characterized by thrombocytopenia, anasarca, a fever, reticulin fibrosis, renal dysfunction, and organomegaly. However, other manifestations have been also reported. We encountered a 43-year-old man with TAFRO syndrome who showed mediastinal panniculitis, liver damage, and adrenal lesions in addition to the core signs. He achieved complete remission with combination therapy of corticosteroids, tocilizumab, and cyclosporin, and remission was maintained even after drug discontinuation at 15 months. Atypical manifestations and complete remission of TAFRO syndrome were remarkable features of our case. 相似文献
72.
Ryohei Sumitani Taiki Hori Jumpei Murai Shiyori Kawata Masahiro Oura Kimiko Sogabe Mamiko Takahashi Takeshi Harada Shiro Fujii Hirokazu Miki Kumiko Kagawa Masahiro Abe Shingen Nakamura 《Internal medicine (Tokyo, Japan)》2021,60(11):1753
A 33-year-old man was admitted to our hospital for fever and abdominal pain. A blood analysis revealed pancytopenia and increased serum pancreatic enzymes with disseminated intravascular coagulation. A detailed examination revealed acute pancreatitis, with diffuse swelling of the pancreas and diffuse beaded dilatation of the main pancreatic duct, which mimicked autoimmune pancreatitis complicated by acute myeloid leukemia. Systemic cytotoxic chemotherapy led to the remission of leukemia and pancreatitis. We hypothesized that the etiology of acute pancreatitis was invasion of leukemia cells. Acute pancreatitis is rare as a symptom of leukemia; however, we should consider the possibility of leukemia during the differential diagnosis of acute pancreatitis. 相似文献
73.
Shinzaki Shinichiro Matsuoka Katsuyoshi Tanaka Hiroki Takeshima Fuminao Kato Shingo Torisu Takehiro Ohta Yuki Watanabe Kenji Nakamura Shiro Yoshimura Naoki Kobayashi Taku Shiotani Akiko Hirai Fumihito Hiraoka Sakiko Watanabe Mamoru Matsuura Minoru Nishimoto Shohei Mizuno Shinta Iijima Hideki Takehara Tetsuo Naka Tetsuji Kanai Takanori Matsumoto Takayuki 《Journal of gastroenterology》2021,56(6):560-569
Journal of Gastroenterology - This multicenter prospective study (UMIN000019958) aimed to evaluate the usefulness of serum leucin-rich alpha-2 glycoprotein (LRG) levels in monitoring disease... 相似文献
74.
Hitoshi Mori MD PhD Daisuke Kawano MD Naokata Sumitomo MD PhD FHRS Shota Muraji MD Taisuke Nabeshima MD Kenta Tsutsui MD PhD Yoshifumi Ikeda MD PhD Shiro Iwanaga MD PhD Shintaro Nakano MD PhD Toshihiro Muramatsu MD PhD Toshiki Kobayashi MD PhD Ritsushi Kato MD PhD Kazuo Matsumoto MD PhD 《Journal of cardiovascular electrophysiology》2021,32(7):1877-1883
75.
Cronkhite-Canada syndrome with colon cancer, portal thrombosis, high titer of antinuclear antibodies, and membranous glomerulonephritis 总被引:6,自引:0,他引:6
Takeuchi Y Yoshikawa M Tsukamoto N Shiroi A Hoshida Y Enomoto Y Kimura T Yamamoto K Shiiki H Kikuchi E Fukui H 《Journal of gastroenterology》2003,38(8):791-795
A 64-year-old man, who came to us with diarrhea, presented with ectodermal changes such as hyperpigmentation, alopecia, and onychatrophy, and was affected by polyposis in the colorectum and stomach. The polyps were histologically consistent with those in Cronkhite-Canada syndrome (CCS). Interestingly, the patient also had colon cancer, as well as portal thrombosis and a high concentration of antinuclear antibody. Treatment with prednisolone ameliorated the symptoms and the gastrointestinal polyposis, while the cancer was successfully treated with a hemicolectomy. Six months after the surgery, the patient developed nephropathy, with nephrotic-range proteinuria, without recurrence of the cancer. The biopsied renal specimen showed membranous glomerulonephritis. This is a rare case of CCS associated with various complications such as colon cancer, portal vein thrombosis, a high titer of antinuclear antibodies, and membranous glomerulonephritis. Although the pathogenesis of CCS is essentially unknown, these complications might have been indicative of an underlying immunological abnormality. 相似文献
76.
Shouichi Ohga Eriko Higashi Akihiko Nomura Akinobu Matsuzaki Akira Hirono Shiro Miwa Hisaichi Fujii† Kohji Ueda 《British journal of haematology》1995,89(2):421-423
Summary. We report the case of a 2-year-old Japanese boy with acute favism who was treated with human haptoglobin products. He had been exhibiting chronic nonspherocytic haemolytic anaemia until the diagnosis of glucose-6-phosphate dehydrogenase (G6PD) deficiency when 14 months old. He suffered a favic crisis at 24 months of age, when the administration of haptoglobin was effective for relieving bilirubinaemia and haemoglobinuria. Serum-free Hb rapidly decreased to normal levels despite the sustained level of serum lactate dehydrogenase. His G6PD gene was G6, Guadalajara. This is the first application of haptoglobin therapy for acute favism and the first reported case of Japanese G6PD deficiency with typical favic crisis. Haptoglobin treatment might be helpful for managing the haemolytic crisis in the disease. 相似文献
77.
Akiyoshi Kashii Susumu Mitani Y. Kasai M. Mito Takashi Suzuki Toshiya Ito Ryoichi Tsuchiya A. Kaneto K. Tanikawa Masanobu Ishida Tsuyoshi Miura Shiro Hayashi Hiroshi Sano Keisuke Yoshida Hiroshi Ito Nobuo Okazaki Nobu Hattori Ichio Honjo Yasuo Kuroyanagi 《Journal of gastroenterology》1973,8(4):393-401
78.
Kisanuki A Yuasa T Kuwahara E Takasaki K Yoshifuku S Otsuji Y Minagoe S Tei C 《Japanese heart journal》2004,45(3):461-473
Few data have been published on the reproducibility of baseline subtracted peak intensity obtained from intravenous intermittent triggered myocardial contrast echocardiography. We investigated the reproducibility of the peak intensity measured from intravenous intermittent triggered myocardial contrast echocardiography in 10 young healthy males. The contrast echocardiography was obtained using the second harmonic mode with an intravenous bolus injection of Levovist (first study). The same myocardial contrast echocardiography was repeated after the first study (second study). The myocardial opacification and peak intensity in the 12 segments of the apical 4 and 2 chamber views were assessed visually and quantitatively. The differences in the peak intensity between the initial and repeated measurements in the first study (intraobserver reproducibility) and between the initial measurements in the first and second studies (interinjection reproducibility) were assessed using the Bland and Altman method. The degree of opacification was good or intermediate in 207/228 (91%) of the segments. The agreement of myocardial opacification between the first and second studies was 87/114 (76%). However, significantly higher peak intensity was obtained in apical septal (8200 +/- 6300 au2) and mid septal (8500 +/- 6000 au2) segments in the 4 chamber view and in the mid inferior (12400 +/- 9300 au2) and apical inferior (10700 +/- 6300 au2) segments in the 2 chamber view compared with other segments. The mean differences of the peak intensities according to the Bland and Altman analysis was -1600 +/- 5000 au2 in the intraobserver reproducibility study, and -1100 +/- 5300 au2 in the interinjection reproducibility study. Thus, the measurement error was determined to range from 8400 au2 to 9500 au2 in both studies. We conclude that the peak intensity obtained from intravenous intermittent triggered myocardial contrast echocardiography using Levovist varies significantly among segments in the left ventricular myocardium. Large intraobserver and interinjection variability exists in the measurement of peak intensity, suggesting that the reproducibility of this technique is limited for quantitative assessment of myocardial perfusion. 相似文献
79.
This retrospective study was aimed at revealing the incidence of normal white blood cell (WBC) count agranulocytosis in patients treated with antithyroid drugs (ATDs). From January 1975 to December 2001, 109 patients (0.35%) presented with ATD-induced agranulocytosis at our clinic. In 18 patients (16.5%), the WBC count exceeded 3.0 x 10(9)/L at the onset of agranulocytosis. Ten showed a downward trend in WBC count (3.0-3.9 x 10(9)/L) after the initiation of ATDs. Four had symptoms of infection. In the remaining 4 patients, routine WBC and granulocyte count monitoring detected an agranulocytosis. During the first 3 months of ATD treatment, 3347 patients (10.9%) had WBC count 3.0-3.9 x 10(9)/L even once with no symptom and normal granulocyte count and 26672 patients had WBC count >or= 4.0 x 10(9)/L with no symptom and normal granulocyte count. When agranulocytosis was found, twelve patients with normal WBC count agranulocytosis (0.36%) had WBC count 3.0-3.9 x 10(9)/L with no symptom, whereas only 2 patients with agranulocytosis (0.008%) had WBC count >or= 4.0 x 10(9)/L with no symptom. In conclusion, clinicians should take normal WBC count agranulocytosis into consideration at least during the first 3 months of antithyroid drug therapy, especially when WBC count is 3.0-3.9 x 10(9)/L. 相似文献
80.
R353Q polymorphism, activated factor VII, and risk of premature myocardial infarction in Japanese men. 总被引:1,自引:0,他引:1
Masakazu Ogawa Satoshi Abe Sadatoshi Biro Masahiko Saigo Takashi Kihara Shiro Setoyama Tatsuru Matsuoka Hitoshi Toda Hiroyuki Torii Yoshihiko Atsuchi Yoshifumi Toyama Shigeki Tateishi Shinichi Minagoe Ikuro Maruyama Chuwa Tei 《Circulation journal》2004,68(6):520-525
BACKGROUND: The association between myocardial infarction (MI) and the R353Q polymorphism of the Factor VII (FVII) gene, which reportedly influences FVII concentrations, activated Factor VII (FVIIa), or FVII antigen (FVIIag), remains controversial. METHODS AND RESULTS: The present case - control study in 127 Japanese men with their first MI at or before 45 years of age and 150 matched healthy controls was designed to clarify this association in premature MI. R353Q polymorphism was determined by polymerase chain reaction, and plasma concentrations of FVIIa and FVIIag were assayed. The distribution of the RR, RQ, and QQ genotypes with respect to R353Q polymorphism was 117, 10, and 0 in the patients, and 131, 17, and 2 in the controls. The Q allele was negatively associated with premature MI (odds ratio =0.41, p=0.038). The plasma concentration of FVIIa was slightly higher in patients (55.1+/-40.9 U/L) than in controls (44.8+/-20.2 U/L), but not significantly (p=0.078); the plasma concentration of FVIIag did not differ between patients (88.7+/-15.7%) and controls (87.0+/-9.0%) (p=0.557). Plasma FVIIa concentrations were influenced by R353Q polymorphism (p<0.001). CONCLUSIONS: The Q allele may be protective against premature MI. 相似文献